09.02.2021
Benchmark Holdings plc
("Benchmark" or the "Company")
Notice of Q1 Results
Webcast for analysts and institutional investors
Equity Development webcast for retail investors
Benchmark Holdings plc (AIM: BMK), the aquaculture health, advanced nutrition, and genetics business, will announce its Q1 results, for the period ended 31 December 2020, on Monday 22 February 2021.
Webcast for analysts and institutional investors at 8:30am UK time
Trond Williksen, Chief Executive Officer and Septima Maguire, Chief Financial Officer will host a webcast for analysts and institutional investors on that day at 8:30am UK time. To register your interest, please contact benchmark@mhpc.com.
Equity Development investor presentation for retail investors at 12pm UK time
Trond Williksen, Chief Executive Officer and Septima Maguire, Chief Financial Officer will host a separate webcast for retail investors and wealth managers at 12.00pm UK time. The webcast is open to all existing and potential shareholders. Questions can be submitted during the presentation to be addressed at the end.
To register for the presentation, please visit: https://zoom.us/webinar/register/9516038965610/WN_DPuJTbmDTbihSCLBZ5DUKw
A recording of the presentation will be available after the event at www.equitydevelopment.co.uk.
Enquiries
|
| ||||||||||||||||||||||||||
|
|
|
About Benchmark
Benchmark's mission is to enable aquaculture producers to improve their sustainability and profitability.
We bring together biology and technology, to develop innovative products which improve yield, quality and animal health and welfare for our customers. We do this by improving the genetic make-up, health and nutrition of their stock - from broodstock and hatchery through to nursery and grow out.
Benchmark has a broad portfolio of products and solutions, including salmon eggs, live feed (Artemia), diets and probiotics and sea lice treatments. Find out more at www.benchmarkplc.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
